The United States Patent and Trademark Office (USPTO) has published an intent-to-use trademark application (TM99338092) for the mark MBELEMED. The application was filed on August 14, 2025, and officially published on March 24, 2026. The mark is intended for use in connection with medical screening services, specifically relating to the heart.

This filing represents a new trademark application and does not impose any immediate compliance obligations on regulated entities. It is primarily an informational notice for parties interested in trademark law and the medical services sector. Interested parties may monitor the application's progress through the USPTO's TSDR system.